Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion.

MLA

Baldwin, Susan L., et al. “Enhanced Humoral and Type 1 Cellular Immune Responses with Fluzone Adjuvanted with a Synthetic TLR4 Agonist Formulated in an Emulsion.” Vaccine, vol. 27, no. 43, Oct. 2009, pp. 5956–63. EBSCOhost, https://doi.org/10.1016/j.vaccine.2009.07.081.

APA

Baldwin, S. L., Shaverdian, N., Goto, Y., Duthie, M. S., Raman, V. S., Evers, T., Mompoint, F., Vedvick, T. S., Bertholet, S., Coler, R. N., & Reed, S. G. (2009). Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion. Vaccine, 27(43), 5956–5963. https://doi.org/10.1016/j.vaccine.2009.07.081

Chicago

Baldwin, Susan L, Narek Shaverdian, Yasuyuki Goto, Malcolm S Duthie, Vanitha S Raman, Tara Evers, Farah Mompoint, et al. 2009. “Enhanced Humoral and Type 1 Cellular Immune Responses with Fluzone Adjuvanted with a Synthetic TLR4 Agonist Formulated in an Emulsion.” Vaccine 27 (43): 5956–63. doi:10.1016/j.vaccine.2009.07.081.